Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation

Zvi Schwartz, D. H. Carney, R. S. Crowther, J. T. Ryaby, B. D. Boyan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A synthetic peptide representing the receptor-binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508-SP. Proliferation ([3H]-thymidine incorporation) was examined in pre-confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]-sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose-dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [ 35S]-sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1 α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH) 2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [ 35S]-sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]-sulfate incorporation was evident up to 48 h post-confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH) 2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508-SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells.

Original languageEnglish (US)
Pages (from-to)336-343
Number of pages8
JournalJournal of Cellular Physiology
Volume202
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

Growth Plate
Cell proliferation
Cartilage
Rats
Cell Proliferation
Phenotype
Alkaline Phosphatase
Sulfates
Proteoglycans
Chondrocytes
Growth
Osteogenesis
rusalatide acetate
Repair
Cell Count
Peptides
Peptide Receptors
Level control
Metabolites
Cell culture

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation. / Schwartz, Zvi; Carney, D. H.; Crowther, R. S.; Ryaby, J. T.; Boyan, B. D.

In: Journal of Cellular Physiology, Vol. 202, No. 2, 02.2005, p. 336-343.

Research output: Contribution to journalArticle

@article{ebd9e961c344435f91aff7b9882b176e,
title = "Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation",
abstract = "A synthetic peptide representing the receptor-binding domain of human thrombin (TP508, also known as Chrysalin{\circledR}) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508-SP. Proliferation ([3H]-thymidine incorporation) was examined in pre-confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]-sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose-dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [ 35S]-sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1 α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH) 2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [ 35S]-sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]-sulfate incorporation was evident up to 48 h post-confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH) 2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508-SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells.",
author = "Zvi Schwartz and Carney, {D. H.} and Crowther, {R. S.} and Ryaby, {J. T.} and Boyan, {B. D.}",
year = "2005",
month = "2",
doi = "10.1002/jcp.20145",
language = "English (US)",
volume = "202",
pages = "336--343",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation

AU - Schwartz, Zvi

AU - Carney, D. H.

AU - Crowther, R. S.

AU - Ryaby, J. T.

AU - Boyan, B. D.

PY - 2005/2

Y1 - 2005/2

N2 - A synthetic peptide representing the receptor-binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508-SP. Proliferation ([3H]-thymidine incorporation) was examined in pre-confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]-sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose-dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [ 35S]-sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1 α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH) 2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [ 35S]-sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]-sulfate incorporation was evident up to 48 h post-confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH) 2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508-SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells.

AB - A synthetic peptide representing the receptor-binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508-SP. Proliferation ([3H]-thymidine incorporation) was examined in pre-confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]-sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose-dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [ 35S]-sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1 α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH) 2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [ 35S]-sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]-sulfate incorporation was evident up to 48 h post-confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH) 2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508-SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells.

UR - http://www.scopus.com/inward/record.url?scp=11144255822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144255822&partnerID=8YFLogxK

U2 - 10.1002/jcp.20145

DO - 10.1002/jcp.20145

M3 - Article

C2 - 15534863

AN - SCOPUS:11144255822

VL - 202

SP - 336

EP - 343

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 2

ER -